€1.84 billionTotal budget of Global Health EDCTP3
€418 millionFunding for 92 projects with clinical trials and scientific studies
€20 millionFunding for 17 projects that strengthen clinical research capacity in sub-Saharan Africa
49 members of EDCTP Association33 African and 16 European countries
406 participating entitiesfrom 64 countries
33 SMEsparticipating in projects
Our projects
Enhancing detection of tuberculosis drug resistanceThe R2D2-xDRTB project is creating a platform to simultaneously evaluate multiple tools for detecting resistance to commonly used TB drugs.
Enhancing clinical research during outbreaksThe ACT-PREP project aims to strengthen capacity for conducting clinical trials in sub-Saharan Africa, with a particular focus on research during...
Improving treatment of cutaneous leishmaniasisThe MAMS4CL project is establishing a clinical trial platform to test improved treatments for cutaneous leishmaniasis, a parasitic disease that...
Factors affecting susceptibility to and severity of mpoxThe DECIPHER-MPOX project is identifying host- and virus-related factors responsible for susceptibility to and the severity of mpox...
Accelerating recovery from choleraThe HUNADIA project is assessing whether a newly developed drug can alleviate the symptoms of cholera, speeding up recovery and shortening or potentially...
Detecting tuberculosis in stool samplesThe STOOL4TB project has been awarded Global Health EDCTP3 funding to complete its EDCTP2-funded study of TB detection in children and people living...
Integrated control of multiple parasitic worm infectionsThe 3SI-CONTROL project is assessing whether it is safe and effective to administer multiple antiparasitic drugs simultaneously and...
Improving treatment of TB meningitisWith Global Health EDCTP3 funding, the EDCTP2-funded INTENSE-TBM project is completing a trial that could radically improve the treatment of tuberculosis...
Our community speaks
‘My message to any young researcher that's considering applying to EDCTP is: do it!’Catherine Hankins, Senior Fellow at the Amsterdam Institute for Global Health & Development
‘This programme facilitates collaboration between North and South and invests in innovation and development of the next generation.’John Gyapong, Vice-chairperson of the Global Health EDCTP3 Scientific Committee
‘Global Health EDCTP3 is unique in addressing the gaps: strengthening the capacity and the innovation components that are essential for the developing countries.’Eleni Aklilu, Professor of Tropical Pharmacology
